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Background: Disabled-2 (Dab2) is an endocytic adaptor protein involved in clathrin-mediated endocytosis and cargo
trafficking. Since its expression is lost in several cancer types, Dab2 has been suggested to be a tumor suppressor. In
vitro studies indicate that Dab2 establishes epithelial cell polarity and organization by directing endocytic trafficking of
membrane glycoproteins. Dab2 also modulates cellular signaling pathways by mediating the endocytosis and recycling
of surface receptors and associated signaling components. Previously, two independent gene knockout studies have
been reported, with some discrepancies in the observed embryonic phenotypes. To further clarify the in vivo roles of
Dab2 in development and physiology, we designed a new floxed allele to delete dab2 gene.
Results: The constitutive dab2 deleted embryos showed a spectrum in the degree of endoderm disorganization in
E5.5 and no mutant embryos persisted at E9.5. However, the mice were grossly normal when dab2 deletion was
restricted to the embryo proper and the gene was retained in extraembryonic tissues using Meox2-Cre and Sox2-Cre.
Adult Dab2-deficient mice had a small but statistically significant increase in serum cholesterol levels.
Conclusion: The study of the new dab2 mutant allele in embryos and embryoid bodies confirms a role for Dab2 in
extraembryonic endoderm development and epithelial organization. Experimental results with embryoid bodies suggest
that additional endocytic adaptors such as Arh and Numb could partially compensate for Dab2 loss. Conditional deletion
indicates that Dab2 is dispensable for organ development, when the vast majority of the embryonic cells are dab2 null.
However, Dab2 has a physiological role in the endocytosis of lipoproteins and cholesterol metabolism.
Keywords: Disabled-2 (Dab2), Primitive endoderm, Extraembryonic endoderm, Morphogenesis, Cell sorting, LDL
receptor, Serum cholesterolBackground
Mouse Disabled-2 (Dab2) was isolated as a 96 kDa
phosphoprotein involved in CSF-1 signaling in macro-
phages, and was initially referred to as p96 [1]. A frag-
ment of the Dab2 human cDNA was also isolated
based on its frequent loss of expression in ovarian can-
cer, and was termed DOC-2 (Differentially expressed
in ovarian carcinoma gene 2) [2]. Sequence homology
suggests that the p96 protein is one of the two mam-
malian orthologs of the Drosophila Disabled gene [3];* Correspondence: xxu2@med.miami.edu
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reproduction in any medium, provided the orhence, that was the origin of the naming for the neur-
onal expressed mammalian Dab1 [4] and the more ubi-
quitously expressed Dab2 [1,5].
The loss of expression of Dab2 in ovarian cancer and
growth regulatory properties in cell culture studies led
to the suggestion that Dab2 is a tumor suppressor in
ovarian cancer [6,7]. Subsequently, loss or reduction of
Dab2 expression was found in other cancer types includ-
ing rat mammary tumors [8], breast cancer [9,10], colon
cancer [11], esophageal cancer [12], urothelial carcinomas
[13], prostate cancer [14], head and neck cancer [15], and
nasopharyngeal carcinomas [16]. Mechanisms were also
suggested for Dab2 in epithelial organization [10,17,18],
and in the regulation of Ras/MAPK [19-22], TGF beta
[15,23,24], and Wnt [25-28] signaling pathways.Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Moore et al. BMC Developmental Biology 2013, 13:39 Page 2 of 14
http://www.biomedcentral.com/1471-213X/13/39Cell biology studies revealed that Dab2 is an endocytic
adaptor protein [29]. Dab2 contains an N-terminal PTB
domain that binds cell surface proteins with an NPXY
motif in their cytoplasmic tails [30]; several motifs that
bind clathrin and adaptin proteins [31]; and a C-terminal
region that binds myosin VI, a directional motor protein
[32,33]. Thus, Dab2 mediates the simultaneous attach-
ment of clathrin-coated cargos containing transmembrane
proteins with one or more NPXY motifs, such as the low
density lipoprotein (LDL) receptor, megalin, and integrins,
to the myosin motor, enabling endocytosis and directional
trafficking. A role of Dab2 in endocytosis and trafficking
of integrins and thus cell mobility has also been suggested
[34,35]. Modulation of LDL receptor endocytosis by Dab2
has also been studied in cultured cells [36], though a role
in vivo has not yet been established. The polarized traf-
ficking of cell adhesion molecules such as integrins and
E-cadherin may explain the role of Dab2 in epithelial
polarity and organization [18] and trafficking of signal-
ing surface receptors may account for its activity in
modulating multiple signaling pathways [5,28,37].
To determine if any of these cellular mechanisms may
be biologically relevant and significant, gene deletions in
mice have been performed [17,38]. A gene replacement
of dab2 allele by betaGal-Neo led to the finding of early
embryonic lethality in the knockout mice [17]. In the
mutants, extraembryonic endoderm cells intermixed with
ectodermal cells in the E5.5 embryos, and a visceral endo-
derm layer failed to develop [17,18]. The aged heterozy-
gous mice were found to develop ovarian cysts and
preneoplastic lesions in both ovaries and uteri [39]. A
flox dab2 mutation was made and the homozygous de-
leted mutant mice were also embryonic lethal, but the
mutant embryos were found to persist to a later stage
[38]. Additionally, a mosaic dab2 deletion using a Meox2-
Cre line was found to produce remarkably normal mice
with minor defects in kidney function [38].
One possibility to explain the discrepancy between
these two dab2 mutant lines is that the expression of
betaGal-Neo in the dab2 mutant embryos [17] might
lead a more severe phenotype. Another idea is that the
dab2 flox mutant allele [38] may produce truncated pro-
teins from an alternative translation start site. Hence,
the later knockouts may not be complete nulls and the
mutant embryos may be able to persist longer.
To investigate the differences in the two knockouts
and to study further the relevant biological functions
and possible tumor suppressor role of Dab2, we have de-
signed another flox dab2 mutant allele with a more ex-
tensive exon deletion, produced the constitutive and
conditional mutant mice, and examined the phenotypes.
Here, we report a detailed characterization of the embry-
onic phenotypes, the conditional knockout mice, the
mutant embryonic stem cells, and the embryoid bodies.Results
Construction of floxed dab2 mutant allele and mice
To investigate further the biological roles of Dab2 in vivo
and resolve the discrepancy in the embryonic phenotypes,
we designed a new dab2 mutant using a Cre/loxP strategy.
The previously reported Dab2 conditional knockout [38]
was designed to delete only exon 3, resulting in a frame-
shift mutant protein. However, exon 4 contains an in-
frame methionine codon that may serve as an alternative
translational start site and produce a truncated Dab2 mu-
tant protein. A homologous targeting construct was
prepared with loxP sites flanking both exons 3 and 4
to avoid the generation of alternative translational
products (Figure 1A).
Upon transfection of ES cells with the linearized tar-
geting construct and G418 selection, 380 independent
drug-resistant clones were picked and screened for hom-
ologous recombination by PCR (Figure 1B). A total of 6
clones were identified as potentially homologous tar-
geted lines, and 2 of the clones were characterized by
PCR as containing the complete targeting construct and
correct homologous replacement at both 5’ and 3’ ends
(Figure 1C). These two lines of ES cells were used for
blastocyst injections, chimeric mouse production, germ-
line transmission, and establishment of the mutant col-
onies. The Neo locus was then removed by crossing with
FLPeR mice [40,41] (Figure 1A). The two lines of the
conditional mutant mice were bred to homozygous
dab2 flox, and the transmission of dab2 (+/+), (+/fl),
and (fl/fl) followed a Mendelian ratio (Additional file 1:
Table S1 and Table S2). Homozygous flox mice exhib-
ited wildtype characteristics with normal Dab2 expres-
sion, reproductive capability, and lifespan. We conclude
that the flox alleles do not influence dab2 gene activity
and the flox mice are essentially wildtype, and the two
dab2 mutant lines are identical.
Characterization of Dab2 constitutive null mutant
embryos
The dab2 flox mice were crossed with Meox2-Cre trans-
genics [42,43] to delete the dab2 gene to generate delta
flox (df ) (Figure 1A). Here, we refer to the dab2-deleted
allele in mosaic mice as “df” and constitutive null in
germ-line deletion as “-”. Next, we selected both male
and female progenies with the dab2 (+/−) genotype for
further matings to investigate the embryonic phenotype of
dab2 constitutive knockouts, referred to as dab2 (−/−).
We initially examined embryos at E4.5 when Dab2 is
expressed in the primitive endoderm [17]. At this implant-
ation stage, dab2 (−/−) embryos were identified by immu-
nostaining for the absence of Dab2 protein (Figure 2). In
wildtype or heterozygous blastocysts, the Gata4-, Gata6-,
and Dab2-positive primitive endoderm cells exclusively lo-
cated on the surface layer covering the Oct3/4-positive
Figure 1 Conditional targeting strategy and screening for homologous recombination of dab2 gene. (A) Schematic illustration of dab2
gene targeting strategy and gene deletion in mutant mice is shown. The targeting construct was made by inserting a neomycin resistance gene
(Neo-R) flanked by Frt sites (closed triangles) between exon 4 and 5. LoxP sites (open triangles) were placed flanking exon 3 and 4. Correct
homologous recombination of the targeting construct did not alter dab2 gene but allowed expression of Neo-R for selection of mutant ES clones.
Following selection and verification, chimeric and then germline mutant mice were made from the mutant ES cells. The Neo-R cassette was excised
by crossing with Flp expression mice to generate the floxed allele. The deletion of exon 4 removed a potential alternative translation start site, indi-
cated as “ATG”. (B) Examples of PCR screening assay of neomycin resistant clones (#25-30) following transfection of linearized targeting construct and
drug selection. Each clone was amplified separately for wildtype (886 bp) and recombinant allele (1714 bp, as predicted). Here, clone #28 was identified
as positive. In the agarose gel: lane 1: Mw markers; lane 2: control mouse DNA; lane 3: KO construct; lane 4: control WT mix, no DNA; 5: control mix for
mutant, no DNA; lanes 6 to 17, amplification using DNA template from clone #25 to 30. (C) Examples of targeted allele in selected clones
(#1, #28, and #121). Here, clone #1 was found to lack the loxP1 site, whereas clones #28 and #121 contained all components: LoxP1,
1714 bp; LoxP2, 795 bp; Frt1, 635 bp; Frt2, 837 bp; and Neo, 617 bp.
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sectioning of 6 uteri, 4 implanted blastocysts were con-
firmed as Dab2-null based on immunostaining. In the
Dab2 knockout embryos, although Gata4- and Gata6-
positive primitive endoderm cells were present, the cells
were not organized into a monolayer epithelium and some
located deep inside the inner cell mass (Figure 2A). Thus
the embryonic defect is initiated at E4.5, post differenti-
ation but prior to morphogenesis of the primitive endo-
derm, although the phenotype is subtle at this stage.
By E5.5, the disorganization of the extraembryonic tis-
sues derived from the primitive endoderm was apparent
(Figure 2B). For comparison, all the Dab2-positive E5.5
embryos, of either dab2 (+/+) or (+/−), were well struc-
tured with a Gata4- and Dab2-positive ring of visceral
endoderm surrounding the epiblast (Figure 2B, WT). A
thin layer of parietal endoderm was present at the outer
layer (Figure 2B, WT, only one Gata4-positive nucleus is
visible in this section, indicated by an arrow). Of the 65
E5.5 embryos sectioned and analyzed, 55 were Dab2-
positive (either wildtype or heterozygous), and 10 were
confirmed as null. In the Dab2-negative E5.5 embryos, Gata4-
positive endoderm cells were misplaced and intermixed withinthe egg cylinder core in all mutant embryos analyzed
(Figure 2B), as shown in the 5 representative examples
of sections through the center of the embryos. Unlike
wildtype embryos that had uniformly well patterned
endoderm epithelium, all mutant embryos showed a
spectrum in the degree of endoderm disorganization
ranging from mild to severe (Figure 2B, mutant em-
bryos #1-5).
Since the previously reported Dab2 mutant embryos
persisted and defective embryos were observed at E9.5
[38], we set up timed matings to genotype embryos spe-
cifically at E9.5 for both dab2 mutant lines. No dissected
embryos were determined as dab2 (−/−) in 12 timed
matings (Table 1). However, a significant number of
reabsorbed embryos, which are likely homozygous mu-
tants, were observed. Thus, we conclude that the current
dab2 mutant embryos exhibit embryonic lethality at
around E5.5 and no embryos can survive to E9.5, con-
sistent with the embryonic phenotype reported for the
betaGal-Neo mutant [17,18]. For E6.5 to E8.5, we observed
putative mutant embryos in a various states of degener-
ation and re-absorption, which we found to be uninforma-
tive and have not systematically characterized them.
Figure 2 Histological phenotypes of constitutively Dab2 null embryos at E4.5 and E5.5. (A) Fixed and paraffin embedded E4.5 embryos in
utero from timed matings of dab2 (+/df) mice were sectioned and stained with H&E to identify implanted embryos. Once found, the serial
sections were used for staining with Dab2 to identify dab2 deletion mutants, adjacent sections were then stained with GATA4 and GATA6 as
markers for primitive endoderm; and with Oct3/4 to identify cells of the inner cell mass. Consecutive sections of a representative Dab2-positive
and a Dab2-negative (dab2 (−/−)) E4.5 embryo are shown. (B) Examples of one wildtype (WT) and five Dab2-negative (dab2 (−/−)) E5.5 embryos
are shown. Dab2 staining was used to identify mutant embryos. An adjacent section was stained for GATA4 to identify the endoderm cells. The
images shown were sections at or near midline (widest area) of the embryos. A spectrum of severity in disorganization of endoderm cells was
seen in the dab2 null embryos. The arrow indicates a parietal endoderm cell in the wildtype.
Table 1 Genotyping of dab2 constitutive mutant embryos
recovered at E9.5
Genotypes
Lines +/+ +/− −/− Reabsorbed
#270 17 21 0 15
#239 15 18 0 16
Note: E9.5 embryos from matings between two lines (#270 and #239) of Dab2
mutant mice of dab2 (+/df) parents were genotyped by PCR. In total, embryos
harvested from12 pregnant females were analyzed. The number of reabsorbed
embryos was noted by visual examination of the uteri.
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We further examined the Dab2 floxed mice using
Meox2-Cre to bypass the essential function of Dab2 in
extraembryonic endoderm. Cre expression initiates in
the epiblast but is absent in extraembryonic tissues [44].
We generated the conditional mutants by crossing fe-
male dab2 (fl/fl) with male dab2 (df/+);Meox2-Cre mice.
Thus, the resulting dab2 (df/fl);Meox2-Cre mice were
expected to be mosaic for deletion of dab2 in the em-
bryo proper. Mice genotyped as dab2 (df/fl);Meox2-Cre
were produced and exhibited no detectable developmen-
tal defects. PCR genotyping of the tail tissues indicated
that 90% of the floxed alleles were deleted, detected as
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“fl” at around 3 weeks of age (Figure 3A). Dab2 is highly
expressed in kidney [6], and immunostaining indicated
kidney proximal tubular epithelial cells were evenly posi-
tive (Figure 3B). However, in the adult conditional knock-
out mice (around 3 months), Dab2 protein was lost in
90% or more of the cells (Figure 3C). Thus, when Meox2-
Cre is used for gene deletion, substantial numbers of non-
recombined cells nevertheless persist in adult mutant
mice.
Subsequently, we used another Cre line, the Sox2-Cre
transgenic [42], in an attempt to delete dab2 to a greater
extent. Like Meox2, Sox2 is expressed in the epiblast but
not in extraembryonic tissues, and Sox2-Cre line can ef-
ficiently delete the floxed gene in the embryo proper
[42,43]. The conditional mutants were generated by
crossing female dab2 (fl/fl) with male dab2 (df/+);Sox2-
Cre mice. Here, male rather than female carriers of
Sox2-Cre were used to avoid a maternal effect, which,
due to Cre expression in oocytes, causes non-Mendelian
transmission [42,43]. We found that the dab2 “fl” allele was
consistently undetectable by PCR in tails of conditionalFigure 3 Conditional dab2 deletion by Meox2-Cre and Sox2-Cre trans
Meox2-Cre or dab2 (df/+);Sox2-Cre mice to produce mosaic mutant mice w
age of 3 months were used for these analyses. (A) An example of PCR gen
from the cross between dab2 (fl/fl) and dab2 (df/+);Meox2-Cre. Specific PCR
performed either separately or in a combined reaction. Examples of Dab2 i
Meox2-Cre (C) mouse are shown, with corresponding PCR genotyping resu
genotyping assay using tail DNA of the progenies (#71 to 94) generated fro
resolving the genotyping PCR products shows a comparison of the dele
Dab2 stainings show the extent of Dab2 mosaicism in the kidney sectio
Meox2-Cre (H) mice.knockouts at 3 weeks of age (Figure 3D). Comparisons of
representative PCR amplifications from heterozygous,
conditional knockouts using Sox2-Cre or Meox2-Cre,
respectively, are shown (Figure E). The kidney from
adult Sox2-Cre conditional knockouts lacked any Dab2-
positive cells (Figure 3F-H). Nevertheless, dab2 (df/fl);
Sox2-Cre mice were produced at a Mendelian ratio and
were devoid of any obvious developmental defects. Both
male and female mutant mice were fertile and had normal
breeding ability when paired with a wildtype partner
(Additional file 1: Table S1 and Table S2).
To address the possibility that a minor fraction of re-
sidual Dab2-positive cells might be involved and critical for
embryonic development and organogenesis, we assessed
the potential presence of Dab2-positive cells in early em-
bryos of Sox2-Cre-mediated conditional dab2 knockout.
Female dab2 (fl/fl) were crossed with male dab2 (df/+);
Sox2-Cre mice to obtain E9.5 embryos in which the em-
bryonic (e) and extraembryonic (ex) tissues were dissected,
discretely separated, and used for PCR genotyping
(Figure 4). In each embryo inheriting Sox2-cre (em-
bryos # 2, 3, 6, 8, 10 in Figure 4), significant levels ofgene. Female dab2 (fl/fl) mice were crossed with male dab2 (df/+);
ithout deletion in the extraembryonic endoderm. Mice of around the
otyping assay using tail DNA of the progenies (#1 to 12) generated
amplifications to identify the locus for cre, fl, df, and wt were
mmunostainings in kidney of a dab2 (df/fl) (B) and a dab2 (df/fl);
lts shown at the upper right corner. (D) An example of PCR
m crosses between dab2 (fl/fl) and dab2 (df/+);Sox2-Cre. (E) DNA gel
tion efficiency generated by Sox2-Cre or Meox2-Cre. Corresponding
ns from dab2 (+/df) (F), dab2 (fl/df);Sox2-Cre (G), and dab2 (fl/df);
Figure 4 Efficiency of dab2 deletion in embryonic and extraembryonic tissues by Sox2-Cre in E9.5 embryos. E9.5 embryos from a timed
mating between female dab2 (fl/fl) and male dab2 (df/+);Sox2-Cre were dissected and harvested for analysis. (A) The example shows the region
dissected as embryo (#1) and extraembryonic tissue (#2). (B) The embryonic (e) and extraembryonic (ex) tissues were separated and used for PCR
genotyping of dab2 gene to determine the presence of Cre (400 bp), df (529 bp), fl (284 bp), and wildtype (wt, 180 bp) allele, to estimate the
efficiency of dab2 gene deletion.
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partments but the allele was undetectable in the em-
bryo proper (Figure 4). An identical conclusion was
reached from analysis of the Sox2-Cre-mediated em-
bryonic and extraembryonic dab2 gene deletion at
E10.5 (not shown). Thus, the efficiency of dab2 gene
deletion by Sox2-Cre was high, and essentially 100% in
embryonic cells by E9.5. Therefore, Dab2 is dispens-
able for tissue formation and organogenesis within the
embryo proper.
Up to now, we have characterized more than 200 pro-
genies with a dab2-deleted genotype and have observed
no obvious developmental phenotype. However, the aged
mice exhibited an increased incidence of preneoplastic
lesions, mainly in the uterus, ovary, mammary gland,
and colon, similar to the previous report for the dab2
heterozygous mice [39]. The studies of the tumor phe-
notypes of aged Dab2 knockout mice and in combin-
ation with p53 mutation will be reported elsewhere.
Role of Dab2 in cholesterol metabolism in vivo
We made additional attempts to determine possible
physiological phenotypes of the Dab2-deficient mice
based on known cellular functions of the Dab2 protein.Dab2 is an endocytic adaptor protein for several NPXY
motif-containing cell surface receptors, including lipo-
protein (LDL) receptor, megalin, and integrins. Endo-
cytosis of megalin mediated by Dab2 is thought to play a
role in protein re-uptake in the proximal tubule cells of
kidney, and previously it was found that excessive pro-
teins were present in the urine from Dab2-deficient mice
[38]. A mild proteinuria phenotype was also observed in
the Dab2-deficient (dab2 (df/fl);Sox2-Cre) mice in our
current study.
In cultured cells, Dab2 co-localizes with the LDL re-
ceptor in clathrin-coated pits [36] and modulates LDL
uptake [45]. Thus, we inquired about the possible role of
Dab2 in LDL uptake in vivo by comparing serum choles-
terol levels between littermates of Dab2 sufficient (dab2
(+/fl);Sox2-Cre) and deficient (dab2 (df/fl);Sox2-Cre)
mice. Serum total cholesterol level was slightly but con-
sistently elevated in Dab2-null over heterozygous mice
(Figure 5). A small difference in serum cholesterol was
found consistently in 4 independent assays using small
(2 to 3 mice for each genotype) groups of mice over a
period of several months. In a more deliberate effort to
compare serum cholesterol in groups of control and
mutant mice shown in Figure 5, we found the small
Figure 5 Increased cholesterol and low density lipoprotein
(LDL) levels in Dab2 deficient mice. Blood was collected for lipid
analysis from 6 month old littermate control and Dab2 deficient
mice with dab2 (df/df);Sox2-Cre genotype. The values are reported
as the average +/− standard deviation. Student T-test indicates the
significance, P < 0.05 for total cholesterol and P < 0.01 for cholesterol
from LDL fraction.
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deficiency influenced mainly the LDL level (p < 0.01),
and had little effect on circulating triacylglycerol, HDL,
and VLDL levels.
In our breeding scheme of using male dab2 (+/df );
Sox2-Cre and female dab2 (fl/fl) parents, no dab2
wildtype littermates were generated to be used as
controls. However, the serum lipid profiles of dab2
(fl/fl) mice were found identical to those of hetero-
zygous and containing Cre transgene (dab2 (+/df );
Sox2-Cre), indicating there was no dosage effect of
dab2 gene nor an impact of Cre expression on chol-
esterol metabolism.Figure 6 Endoderm disorganization of Dab2 knockout embryoid bod
between dab2 (+/df) parents were genotyped by PCR and allowed to form
examples of heterozygous dab2 (+/−) and homozygous dab2 (−/−) embryo
(A) Sections were stained for the presence of Dab2 (green), endoderm ma
at low (top panels) and higher magnification (lower panels) are shown. (B)
laminin (red) to indicate primitive endoderm epithelia, and counter-stained
cation) and middle (higher magnification) panels. Laminin staining (red) alo
and the presence of a thin basement membrane underlying the endoderm
and no such basement membrane layer was observed in the dab2 null emThus, the results support the findings from cell culture
studies [36,45] that Dab2 is involved in LDL receptor
endocytosis and LDL uptake, and suggest that Dab2 has
a physiological role in cholesterol metabolism.
Analysis of dab2-null embryoid bodies and embryos for
adaptor proteins
We generated several lines of both dab2 heterozygous
(+/−) and homozygous (−/−) mutant ES cells from blas-
tocysts for further study. Previously, embryoid bodies
derived from ES cells in which Dab2 expression was
suppressed by shRNA were defective in the organization
of primitive endoderm layer [18]. The ability of dab2-
null ES cells to form embryoid bodies was tested. In sev-
eral Dab2 mutant clones analyzed, primitive endoderm
differentiation occurred, but the Gata4-positive endo-
derm cells failed to form an epithelial layer on the sur-
face of the embryoid bodies (Figure 6A). In heterozygous
and wildtype controls, a layer of laminin-positive base-
ment membrane was observed (indicated by arrows in
Figure 6B), indicating the formation of an epithelium. In
Dab2-negative embryoid bodies, the differentiated primi-
tive endoderm cells were positive for laminin; however,
neither an endoderm epithelium nor a basement mem-
brane layer was evident (Figure 6B).
Nevertheless, phenotypic variations were observed
among the five dab2 (−/−) ES clones isolated. A clone of
dab2 (−/−) ES cells (dfg15) was observed to have a mild
positioning phenotype, in that some monolayer endo-
derm epithelial structures were observed in a portion of
embryoid bodies derived from this clone (Figure 7A, ar-
rows). We suspect that additional endocytic adaptorsies. Clones of ES cells isolated from blastocysts derived from matings
embryoid bodies in suspension cultures for 5 days. Representative
id bodies were analyzed by immunofluorescence microscopy.
rker GATA4 (red), and counterstained with DAPI (blue). Merged images
Sections were stained for the pluripotent marker Oct3/4 (green),
with DAPI (blue). Merged images are shown at the top (low magnifi-
ne from the corresponding middle panels is presented at the bottom,
epithelium in the wildtype embryoid bodies is indicated by an arrow,
bryoid bodies.
Figure 7 Mild defective positioning phenotype in embryoid bodies and compensatory expression of Arh and Numb in Dab2 null ES
cells and embryos. (A) In some of the dab2 (−/−) ES clones (such as clone dfg15), a monolayer epithelial structure is seen at some of the
surface of embryoid bodies (indicated by arrows), as shown by an example of a section stained with Dab2 (green) (no signal in this image),
GATA4 (red), and DAPI (blue). (B) Western blot shows that Arh and Numb were variably expressed in embryoid bodies derived from several ES
cell clones of different dab2 genotypes. (C) The expression of Dab2, Arh, and Numb adaptors proteins was analyzed by Western blotting of E9.5
embryos from matings between female dab2 (fl/fl) and male dab2 (+/df); Sox2-Cre. The embryos were harvested, dissected free of extraembryonic
tissues, lysed and denatured in SDS buffer, and probed for Dab2, Arh, and Numb. The extraembryonic tissues were used for genotyping.
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[31], might be able to substitute for Dab2 function and
rescue the endoderm disorganization in a subset of Dab2
mutant embryoid bodies. Indeed, we found that Numb
and Arh proteins were expressed in differentiated ES cells
in embryoid bodies, and the expression varied among
clones (Figure 7B). Compared to other ES clones, the cells
of the dab2 (−/−) clone dfg15 had higher Arh and Numb
expression. Additionally, expression of Arh and Numb ap-
peared to change with passage in culture. Thus, the com-
pensatory expression of Numb and/or Arh may rescue
primitive endoderm disorganization in embryoid bodies to
some degree when dab2 gene is deleted. Future experi-
ments using combinative deletions or forced overexpres-
sion of the adaptors will be needed to test this possibility.
We further determined if compensatory expression of
Arh and Numb adaptor proteins occurred in dab2 knock-
out embryos. E9.5 embryos from matings between female
dab2 (fl/fl) and male dab2 (+/df);Sox2-Cre were har-
vested, and the entire embryo propers dissected free of ex-
traembryonic tissues were analyzed by Western blotting
(Figure 7C). Although some variation in levels of Numb
and Arh expression were visible in dab2 heterozygous
E9.5 embryos, global expression of Numb and Arh pro-
teins was consistently elevated in the four dab2-deleted
embryos analyzed (Figure 7C), suggesting there was com-
pensatory expression of Arh and Numb in the absence of
Dab2 during embryonic development. Dab1, the other
Drosophila Disabled ortholog, was undetectable in ES cellsor E9.5 embryos, either wildtype or mutant. Involved in
neuronal migration and with a brain-restricted expression
[4], Dab1 likely has little function or expression overlap
with Dab2.
Discussion
The current dab2-conditional deletion mouse model has
verified the critical role of Dab2 in the organization of
the primitive endoderm [17,18]. However, normal devel-
opment following its deletion in the embryo proper indi-
cates that the previously suggested roles of Dab2 in the
regulation of signaling pathways in unchallenged physio-
logical situations are either very subtle or redundant
in vivo.
Mechanism of epithelial organization and the embryonic
lethal phenotype of dab2 knockout mice
The current study confirms the previous observations
that Dab2 deficiency leads to disorganization of the ex-
traembryonic endoderm [17,18]. Moreover, we observed
primitive endoderm disorganization at E4.5, a stage that
immediately follows blastocyst implantation. The extra-
embryonic endoderm cells are present in Dab2-deficient
embryos, but intermingled with the epiblast cells instead
of forming a surface epithelial layer. This phenotype of
Dab2-deficient embryos prompts us to describe dab2 as
an “epithelial surface positioning gene” [18], in parallel
to the manner in which dab1 is referred to as a “neuronal
positioning gene” [4]. The proposed mechanism is that
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endoderm epithelial cells, leading to the establishment of
an apical polarity [18,46]. Previously, it was considered
that the highly adhesive embryonic cells sort to inside and
less adhesive cells sort to the periphery [47], according to
the Differential Adhesion Hypothesis [48,49]. However, in
the case of the mouse primitive endoderm, the ability to
establish apical polarity rather than differential adhesive
affinity determines the anchoring of the primitive endo-
derm layer at the surface [46]. Thus, deletion of dab2
leads to the loss or reduced trafficking of cell surface
adhesion molecules, consequently a reduced ability to
establish a polarity, and finally the failure of primitive
endoderm cells to position at the surface [18,46].
Additionally, deletion of c-fos can partially rescue endo-
derm disorganization in the Dab2-deficient embryos [22].
Dab2 can negatively modulate c-Fos expression [19], and
c-Fos can regulate epithelial polarity [50]. Thus, Dab2 may
also impact endoderm cell organization through its influ-
ence on the MAPK/c-Fos signaling pathway. Although, it
was reasoned previously that additional activities of Dab2
other than suppression c-For might impact organogenesis
[22], the current result indicates Dab2 developmental re-
quirement is restricted to extraembrynic endoderm. How-
ever, it is still possible that Dab2 expression within
extraembryonic endoderm may influence embryonic de-
velopment by a non-cell autonomous mechanism.
Lack of developmental phenotypes in dab2 mosaic
mutant mice
Considering that the loss of Dab2 in primitive endoderm
leads to the disruption of epithelial organization and a
severe phenotype in early embryos, we were perplexed
that dab2 conditional knockouts generated using either
Meox2-Cre or Sox2-Cre showed no developmental de-
fects and had relatively mild adult phenotypes. One pos-
sibility is that remnant Dab2-positive cells in the mosaic
dab2 mutant mice are sufficient for essential develop-
mental functions. Alternatively, expression of endocytic
adaptor proteins such as Numb and Arh, which have
similar structures and functions as Dab2 [31], may com-
pensate when dab2 is deleted. Based on PCR genotyping
of tail tissues and immunostaining of kidney, we esti-
mated that around 5-10% of the cells still contain unde-
leted dab2 gene in Meox2-Cre conditional knockout.
Conversely, the “fl” allele was undetectable in Sox2-Cre
knockout lines, yet the percentage of Dab2-positive cells
could be higher in the earlier stages of embryonic devel-
opment. Sox2 is expressed in and essential for the
trophoblast extraembryonic lineage [51,52]. However,
Sox2-Cre-mediated deletion of dab2 gene did not affect
trophectoderm development, thus Dab2 is also not es-
sential in at least a subset of the trophoblast lineage. Al-
though the dab2 gene can be deleted in the majority ofsomatic cells without affecting embryonic development,
we considered the possibility that a miniscule fraction of
Dab2-positive cells may be sufficient to fulfill its poten-
tially critical roles. Nevertheless, we did not detect any
remaining dab2 allele in E9.5 Sox2-Cre conditional
knockout embryos. Most likely, compensatory expres-
sion of Dab2-like proteins such as Arh and Numb
accounted for a mild phenotype and the actual forma-
tion of primitive endoderm structures observed in some
of the Dab2-deficient embryoid bodies.
Dab2 mediates endocytosis and contributes to
lipoprotein metabolism in vivo
Although Dab2-deficient mice were overtly normal, mu-
tant mice did have several physiological differences, such
as excessive excretion of plasma proteins in urine and
increased serum cholesterol and LDL. These physiological
phenotypes might be attributable to the adaptor activity of
Dab2 for megalin and LDL receptor, respectively. Another
well-documented Dab2 binding ligand is integrin [34,35].
Though an impact of Dab2 on cell migration was ob-
served in cultured cells, we found no related physiological
phenotype in the mutant mice. Dab2 also has been re-
ported to have many other activities, but these phenotypes
were also not readily observable in the mutant mice.
In the case of LDL receptor endocytosis, the increased
cholesterol and low density lipoprotein levels in Dab2
deficient mice was small but readily detectable. The in-
creased serum cholesterol and LDL levels was likely due
to the absence of Dab2 protein in mediating uptake of
LDL particles from circulation by Dab2-mediated endo-
cytosis. The results support the findings in cell culture
studies [36,45] that Dab2 is involved in LDL receptor
endocytosis and LDL uptake, and suggest that Dab2 has
a physiological role in cholesterol metabolism. Normally,
mice have a relatively low level of serum LDL. Possibly,
the difference in serum cholesterol and LDL levels
would be more significant in Dab2-deficient mice when
the animals are placed on a high fat diet. The impact of
Dab2 on cholesterol metabolism, the cell types affected,
and comparison with LDL receptor and Arh mutant
mice, will be interesting topics of future investigations.
Likely, as an endocytic adaptor for several cell surface
receptors, Dab2 may influence the endocytosis and se-
cretion of multiple ligands, and may regulate multiple
signaling pathways. The function of Dab2 is pleiotropic,
although it may serve as a fine tune regulator of signal-
ing and an endocytic adaptor with overlapping specificity
with other adaptors, but the impact of its deletion is
mild when observed in normal physiological setting.
However, additional phenotypes and Dab2 functions
may be observed in deeper analysis of the Dab2 deficient
mice, and also when placing the mutant mice in a chal-
lenged situation.
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Dab2 has been implicated in regulating signaling path-
ways, including the Ras/MAPK/c-Fos [19-22], the TGF-
beta [15,23,24], and the Wnt pathways [25-28]. Dab2
also participates in the endocytic recycling of E-cadherin
[18] and integrins [35] and thereby influences cell adhe-
sion and mobility. It is plausible that Dab2 affects these
diverse cellular signaling pathways due to its role in
endocytosis and trafficking; however, whether these ac-
tivities are physiologically significant has not been re-
solved previously. The Ras/MAPK pathway [53-59], the
TGF-beta pathway [60], the Wnt pathway [61,62], E-
cadherin [63,64], and integrins [65] are all critical in em-
bryonic development and their perturbations impair the
process. Since Dab2 deletion in the embryo proper min-
imally impacts embryonic development, we would argue
that the majority of the proposed Dab2 functions gener-
ated from these in vitro studies have little relevance
in vivo. Dab2 may fine-tune the activities of these signal-
ing pathways, but the effects are subtle and not readily
observable in the normal physiology of whole animals.
Loss of Dab2 in epithelial disorganization and cancer
One common observation in both early embryonic de-
velopment and carcinogenesis is that loss of Dab2 leads
to epithelial morphological transformation. The loss of
Dab2 correlates well with morphological changes, specif-
ically the transition from a simple epithelial monolayer
to a multiple layered neoplasm in ovarian cancer [66].
This is remarkably reminiscent of the disorganization
and loss of surface position of primitive endoderm in
dab2-deficient embryos and embryoid bodies. Dab2-
mediated directional endocytic trafficking leads to the
generation of an apical-basal epithelial polarity, and po-
larity plays critical role in surface positioning [18]. Thus,
loss of Dab2 results in epithelial depolarization and sub-
sequent disorganization, as found in ovarian carcinomas
and early embryos [17,18,39,66]. However, ovarian sur-
face epithelia are monolayered and intact in dab2-defi-
cient mice (not shown), indicating the loss of Dab2
alone is insufficient to induce epithelial disorganization.
Unlike the primitive endoderm epithelium in rapidly grow-
ing embryos, mature epithelia in adults most likely possess
additional mechanisms to ensure stable architecture.
Conclusion
The current results in the study of a new dab2 condi-
tional mutant allele are consistent with the prior report
that dab2 deletion leads to an early embryonic lethality
at E5.5 [17,18]. This lethality occurs much earlier than
the other report of mutants derived from a previously
reported conditional allele [38]. Consistent with our prior
conclusion [18,19], the current analysis of both embryos
and embryoid bodies indicates that loss of Dab2 leads todisorganization of primitive endoderm and subsequent ex-
traembryonic endoderm, although the differentiation to
endoderm lineage is not impaired. Thus, the current study
clarifies the discrepancy in embryonic phenotypes de-
scribed for the two previous knockouts [17,38].
Conditional deletion indicated that Dab2 is dispens-
able for organ development, when the vast majority of
the embryonic cells are dab2 null. A possibility is that
additional endocytic adaptors such as Arh and Numb
partially compensate for Dab2 loss. However, Dab2 has a
physiological role in the endocytosis of lipoproteins and
cholesterol metabolism.
Methods
Construction of the dab2 homologous recombination
targeting vector and conditional mutant mice
Using the mouse Dab2 cDNA as a probe, three clones
(λ20, λ24, and λ28) of mouse genomic DNA containing
the dab2 gene were isolated from a 129/Sv genome li-
brary in λZap (Stratagene) [67]. The λ24 fragment, span-
ning exons 2 to 11 of the dab2, was cloned at the Eco RI
site of pBSKS, and was used as a template for PCR
amplifications. A 5.8 kb genomic fragment covering
exons 5 to 9 was PCR-amplified with a Not I-anchored
sense primer (5′-ATG GAT GCG GCC GCT CCC GGA
AAT GGT TAC-3′) and antisense primer (5′-ATG ATG
GAT CTT TGG TTG TTG T-3′). The resulting PCR
fragment was recloned into Apa I/Not I restricted pK11/
pM30 Frt-PGKNeo-Frt-LoxP-pBSSK plasmid (from
Dr. David W. Martin, Emory University) which was first
modified by cloning a polylinker (Apa I-Sac I-Not I-Stu
I-Kpn I) at Apa I/Kpn I sites with the sequence of 5′-
CAT GAG CTC AGG CGG CCG CAT AGG CCT AAG
GTA C-3′. A 1.7 kb genomic fragment containing exon
2 was PCR-amplified with Cla I-anchored sense primer
(5′-ATC GAT CTG CAG TGA GGA TCC TGA ATA
CTA TCT CTC GGT ACT-3′) and Sal I-Sac I-anchored
antisense primer (5′-ATC GAT GTC GAC TGA GAG
CTC CAC ATT CTG CTA ATA TGT CAT C-3′) and
inserted into Cla I/Sal I restricted BstLox2 vector (also
provided by Dr. D.W. Martin) upstream of the LoxP site
near the T7 RNA promoter. A 2.8 kb fragment containing
exons 3 and 4 was PCR-amplified with Sac II-anchored
sense primer (5′-ATC GAT CCG CGG GAA TGA ATC
CTA CCA TGG-3′) and Eco RV-anchored antisense pri-
mer (5′-ATC GTA GAT ATC AGC CTG CCA GAG
CTG GAG-3′) and recloned into Eco RV/Sac II restricted
BstLox2 vector downstream of the LoxP site. The sub-
cloned fragment of 4.4 kb containing exon 2-Loxp-exon 3
and 4 of the dab2 gene was then digested with Sac I and
Sac II and recloned into pK11/pM30 Frt-PGKNeo-Frt-
LoxP-exons 5 to 9 to generate the final targeting con-
struct. Each PCR fragment generated was amplified using
cloned-Pfu DNA polymerase (Stratagene), which has a
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lication. At each cloning step, several clones were verified
by restriction analysis and sequencing. The targeting vec-
tor was linearized with Sac I and Avr II to obtain an
11.7 kb fragment that was electroporated into RW4 ES
cells.
The selection, screening, and blastocyst injection to
produce chimeric mice were performed with assistance
from the institutional transgenic mouse facility accord-
ing to standard procedures. Neomycin resistant ES cell
clones were screened for homologous recombination by
PCR using discriminating primers spanning sequences
both inside and outside the targeting construct. The se-
quences of the primers are listed: P5′: 5′-CCA GTA
CAC CAC GTA AGA AAG-3′; P3′ for WT: 5′-ACA
GTC ACT GAT ACC AGC CAA-3′; P3′ for KO: 5-
AGT TAT TAG GTC CCT CGA CCT-3′. The frag-
ments from PCR amplification were predicted to be
886 bp for wildtype (WT) and 1714 bp for the recom-
binant allele. The positive clones were further character-
ized by PCR to ensure the allele contained all the
component of the targeting construct: LoxP 1, 1714 bp
(P5′: 5′-CCA GTA CAC CAC GTA AGA AAG-3′; P3′:
5-AGT TAT TAG GTC CCT CGA CCT-3′); LoxP 2,
795 bp (P5′: 5′-ACA TTA TAC GAA GTT ATT CGA
GG-3′; P3′: 5′-ATC ACA GTT GGC GTC ATA ACA
A-3′); Frt1, 635 bp (P5′: 5′-CAC CTG ATC TGA CTG
TGG TT-3′; P3′: 5′-AGA GAA TAG GAA CTT CGG
CC-3′); Frt2, 837 bp (P5′: 5′-ACT ATA GGA ACT
TCG TCG ACC-3′; P3′: 5′-ATC ACA GTT GGC GTC
ATA ACA A-3′); Neo, 617 bp (P5′: 5′-GGC ATT CTC
GCA CGC TTC AA-3′; P3′: 5′-CTT GAG CCT GGC
GAA CAG TT-3′).
Two selected recombinant ES clones, #28 and #121,
were used for blastocyst injection to establish mutant
lines. The neo locus flanked by Frt sites was then ex-
cised by crossing with FLPeR mice [40,41]. Two lines of
dab2 flox conditional knockout mice (lines 239 and
270) were established from the two independent ES
clones and the mouse colonies were maintained in the
C57BL/6 J background. The two lines gave identical phe-
notypes and were not distinguished here unless specific-
ally mentioned.
Mouse strains and husbandry
Flp expression mice (129S4/SvJaeSor-Gt(ROSA)26Sortm1
(FLP1)Dym/J) [40,41], Meox2-Cre mice (B6.129S4-Meox2tm1
(cre)Sor/J) [44], and Sox2-Cre mice (Tg(Sox2-cre)#Amc/J)
[42,68] were purchased from Jackson Labs.
Control and mutant mice were kept in the institutional
mouse facility as inbred colonies by pairing parents of
selected genotypes. Upon weaning, the mice were geno-
typed and separated into experimental and control groups
accordingly. The mice were caged in barricaded viralpathogen-free rooms under a 12-hour light–dark cycle,
with free access to food and autoclaved water. For dietary
studies, the mice were kept on a 5 K20 chow (LabDiet:
17% protein, 10% fat, 2.5% fiber, 8% ash, and 3.5% added
minerals). All procedures for experiments using animals
were reviewed and approved by the University of Miami
Miller School of Medicine Institutional Animal Care and
Use Committee and followed National Institutes of Health
guidelines.
Measurement of serum lipids
Mice were fasted for 6 hours and then anesthetized be-
fore blood was collected by cardiac puncture. Blood
samples were allowed to clot for 15 min and centrifuged
for 10 min in a bench top centrifuge. The serum super-
natants were collected and stored at −80°C until use.
Lipid analysis was performed by the University of Miami
Comparative Pathology Laboratory using a Vitros 250
chemistry analyzer (manufacturer: Johnson & Johnson).
Cholesterol, triglycerides, and high-density lipoprotein
(HDL) levels were measured colorimetrically. Low-density
lipoproteins (LDL) and very low-density lipoprotein
(VLDL) levels were derived from the following for-
mula: VLDL = 1/5 of triglycerides; LDL = total choles-
terol minus HDL and VLDL).
Derivation of dab2 null ES cells and the formation of
embryoid bodies
Blastocysts were harvested at E3.5 after timed-matings
between dab2 (+/−) parents. The blastocysts were indi-
vidually cultured in single wells of 24-well tissue culture
plates previously coated with irradiated murine embry-
onic fibroblasts (MEF). The blastocysts were allowed to
hatch and attach to the fibroblast feeder layer. Cells
from the outgrowth of blastocysts were expanded and
these clones were established and characterized to con-
firm as ES cells, as described previously [69]. Established
ES cells were maintained in a pluripotent state by cultur-
ing on an irradiated MEF feeder layer in media supple-
mented with 1000 U/ml of recombinant LIF (ESGRO,
Chemicon International).
To produce embryoid bodies, approximately 6 × 106
ES cells were suspended in 10 ml of medium lacking LIF
on non-adhesive Petri dishes and allowed to aggregate
for 5 to 7 days. After the first two days, 5 ml of fresh
medium was added to the plates. Afterward, the medium
was then changed every other day by collecting the cell
aggregates with brief centrifugation (2,000 g for 1 min)
and re-suspending the aggregates in fresh medium by
gently pipetting the aggregates. In some experiments,
retinoic acid (1 μM) was added in the medium to enhance
endoderm differentiation. At the end of each experiment, the
cells aggregates were collected and processed for Western
blot or histology analysis. The starting concentrations of ES
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are in a size range of 20–100 μm, which is comparable to the
size of embryo cross sections at E5.5 stage.
Genotyping
At earlier stages (E5.5 and E4.5), dab2 genotyping was
performed by examining the morphology and/or Dab2
immunostaining of the embryos to distinguish dab2
(+/+) or (+/−) from (−/−) genotypes.
For embryos at later stages (E9.5) and adult mice,
DNA was extracted from entire embryo proper, yolk
sacs, or tail biopsies. PCR amplification with primers 5′-
TAC AGG CAT CCC CAT TTT TG -3′, 5′-TGC CAC
CTA CAA GGA AGG AC-3′, and 5′-ACA GGC TGT
GCA GTC TCG TA-3′ generated amplicons of 180 bp
(dab2 wildtype, or wt), 284 bp (flox, or fl), and 529 bp
(delta flox, or df). Cre alleles were amplified using the
generic Cre primers: 5′-CCT GGA AAA TGC TTC
TGT CCG -3′ and 5′-CAG GGT GTT ATA AGC AAT
CCC-3′ to generate a 400 bp fragment.
Histology, histochemistry, and immunofluorescence
microscopy
Embryos from timed matings were harvested either
while in utero (up to E7.5) or as individually dissected
embryos (E9.5). Part of the later stage embryos was used
for genotyping. The collected specimens were processed
by formalin fixation and paraffin embedding. The ar-
chived tissues were then sectioned and processed for
histology and immunofluorescence microscopy.
Primary antibodies used in this study were: mouse mono-
clonal anti-Dab2 (BD Transduction Laboratories); rabbit
polyclonal anti-Dab2 [18]; rabbit polyclonal anti-Gata4 anti-
bodies (Santa Cruz Biotechnology, Inc.); rabbit pan anti-
laminin (Abcam); rabbit polyclonal anti-GATA6 [70]; mouse
monoclonal anti-Oct3/4 (Santa Cruz Biotechnology); mouse
monoclonal anti-Arh (Santa Cruz Biotechnology, Inc.); goat
polyclonal anti-Numb (Abcam), and mouse monoclonal
anti-beta-actin (BD Transduction Laboratories). DAPI (4′-
6-diamidino-2-phenylindole) was used as a generic nuclear
counterstain and applied at the terminal stages of the
procedure.
Conventional wide-field microscopy was performed on
an inverted Zeiss AxioObserver Z1 operated by Axio Vi-
sion 4.8 software. Images were acquired digitally with a
monochrome Zeiss AxioCam MRm CCD camera.
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Additional file 1: Table S1. Partial breeding record for dab2 (fl/+) mice
from line 239. Table S2. Partial breeding record for dab2 (fl/+) line 270.
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